Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device
- 18 November 2004
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 20 (S2) , S24-S31
- https://doi.org/10.1002/dmrr.516
Abstract
Background Pre‐prandial glucose gives insufficient information on glycemic excursions throughout the day. We aimed to test a continuous subcutaneous glucose‐monitoring device (GlucoDay®) to describe postprandial glucose changes. Methods In 23 T1DM patients, 24‐h GlucoDay® registrations were started about 14 h before receiving a standard breakfast B and 3 h later lunch L. Results The 3‐min glucose values were computed into parameters describing the postprandial changes after B and L. Two‐hour glucose was higher after B (243 ± 69 vs 180 ± 79 mg/dL after L, p < 0.0001). Maximum glycemia (313 ± 105 mg/dL after B and 304 ± 119 after L, p < 0.0001) was higher and was reached after 78 and 57 min respectively. Three‐hour AUC was higher but 30‐min AUC was lower after B (5725 ± 2414 vs 7488 ± 2208 min mg/dL after L, p = 0.004). Glucose spikes (maximum peak minus fasting plasma glucose) were similar after B and L but the difference between maximum and minimum values was smaller after B (165 ± 110 vs 219 ± 115 mg/dL after L, p = 0.020). Duration of hyperglycemic periods >200, 140 or 126 mg/dL were not different after B or L, but time spent at glucose p < 0.0001). Conclusions These results illustrate the use of subcutaneous glucose registration to characterize postprandial glycemia patterns in T1DM. Application of such methods to evaluate this and other clinical situations in DM can lead to therapeutic and dietary adjustments and ultimately improve glycemic control. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Point: A Glucose Tolerance Test Is Important for Clinical PracticeDiabetes Care, 2002
- Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.Diabetes Care, 2000
- Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.Diabetes Care, 2000
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 1999
- Is there a glycemic threshold for mortality risk?Diabetes Care, 1999
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upDiabetologia, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.BMJ, 1983